L-beta-hoMoserine-HCl(1245645-62-8)
- Name: L-beta-hoMoserine-HCl
- Synonyms:UNII-3VYM1G0Y0X;
- Molecular Formula:C4H10ClNO3
- Molecular Weight:155.5801
- CAS Registry Number:1245645-62-8
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 477732-88-0/SALOR-INT L239569-1EA
- 793724-11-5/1,2,5-Oxadiazole-3-carboxylicacid,4-ethoxy-,ethylester,2-oxide(9CI)
- 201988-71-8/H-CIT-BETANA HBR
- 135380-24-4/6-METHYL-2,6-DIAZASPIRO[3.4]OCTANE
- 1350317-29-1/B-[4-[4-(methylamino)-4-oxobutoxy]phenyl]boronic acid
- 71840-27-2/2-Methylpropionic acid 2-tert-butyl-6-[(3-tert-butyl-2-hydroxy-5-methylphenyl)methyl]-4-methylphenyl ester
- 897940-14-6/3-Fluoro-2-(trifluoromethyl)ph
- 1314903-55-3/3-amino-4-(2-propen-1-yl)Phenol
- 66269-66-7/(+/-)-COTININE-D3
- 1533932-57-8/Methyl 3-bromo-5-fluoro-4-methylbenzoate
- 6797-96-2/N-[4-[(3-Carboxy-4-hydroxy-6-sulfonato-1-naphthalenyl)[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methylmethanaminium
- 1008961-08-7/(2,5-DIOXO-1-PROPYL-IMIDAZOLIDIN-4-YL)-ACETIC ACID
- 1209264-64-1/5,6,7,8-TetrahydroiMidazo[1,2-a]pyriMidine hydrochloride
- 890099-57-7/3-ACETOXY-2'-BROMOBENZOPHENONE
- 1190311-18-2/3-AMino-5-broMo-4-azaindole
- 1245645-62-8/L-beta-hoMoserine-HCl
- 1188047-07-5/7-BroMobenzo[d]thiazol-2(3H)-one
- 1179360-57-6/3-[4-(3-methylbutoxy)-2-pyridinyl]-1,2,4-Thiadiazol-5-amine
- 4947-69-7/(22S,23S,25R)-23-Bromo-5α-spirostane
- 73899-14-6/3-Phenyl-3-(trifluoroMethyl)diazirine
- 68331-40-8/(E)-4-CYANO STILBENE
- 609793-28-4/SALOR-INT L431893-1EA
- 1269291-66-8/2-(HydroxyMethyl)-5-(trifluoroMethyl)pyridine
- 1314703-47-3/tert-butyl 4-(azetidin-3-yl)piperidine-1-carboxylate
- 29917-69-9/1-(p-Methoxyphenyl)-3-phenyl-2-propanone
- 166328-10-5/POTASSIUM (2-FLUOROPHENYL)TRIFLUOROBORATE
- 1346692-17-8/5-(3-Chloro-5-fluorophenyl)nicotinaMide
- 15039-66-4/3,4,6a,7,9,9a-Hexahydro-4,11,13,15,18-pentahydroxy-1,3,7,9-tetramethyl-1H-[2]benzopyrano[6,7-f]naphtho[2',3':4,5]pyrano[4,3-b][1,4]benzodioxin-5,10,19(15H)-trione
- 827006-84-8/2-AMINO-N-(4-FLUOROBENZYL)BENZAMIDE
- 102586-22-1/FC 473